Gland Pharma Limited (NSE: GLAND)
India flag India · Delayed Price · Currency is INR
1,779.45
+14.65 (0.83%)
Dec 24, 2024, 3:30 PM IST

Gland Pharma Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2017
Revenue
58,90156,64736,24644,00734,62926,332
Upgrade
Revenue Growth (YoY)
36.81%56.29%-17.64%27.08%31.51%28.81%
Upgrade
Cost of Revenue
27,03025,53918,59522,49416,09712,155
Upgrade
Gross Profit
31,87231,10817,65121,51318,53214,178
Upgrade
Selling, General & Admin
13,92212,6684,0473,3973,1222,784
Upgrade
Other Operating Expenses
4,9714,8953,2713,0092,3851,823
Upgrade
Operating Expenses
22,94421,2238,8077,5136,4985,569
Upgrade
Operating Income
8,9289,8858,84414,00012,0348,609
Upgrade
Interest Expense
-225.57-217.9-62.87-34.02-29.11-62.51
Upgrade
Interest & Investment Income
1,5061,5061,7941,386859.49514.86
Upgrade
Currency Exchange Gain (Loss)
106.05106.05571.45792.05405.26693.11
Upgrade
Other Non Operating Income (Expenses)
212.989.1-1.07-2.8577.77-0.6
Upgrade
EBT Excluding Unusual Items
10,52711,28811,14616,14213,3489,754
Upgrade
Gain (Loss) on Sale of Investments
3.483.4828.4844.89--
Upgrade
Gain (Loss) on Sale of Assets
2.492.49-0.81-1.780.24173.93
Upgrade
Asset Writedown
---63.32---
Upgrade
Other Unusual Items
---564.61---
Upgrade
Pretax Income
10,56411,32510,54616,18613,3489,929
Upgrade
Income Tax Expense
3,6483,6012,7354,0693,3782,200
Upgrade
Net Income
6,9167,7257,81012,1179,9707,729
Upgrade
Net Income to Common
6,9167,7257,81012,1179,9707,729
Upgrade
Net Income Growth
-1.04%-1.10%-35.54%21.54%29.00%71.04%
Upgrade
Shares Outstanding (Basic)
165165165164158155
Upgrade
Shares Outstanding (Diluted)
165165165165158155
Upgrade
Shares Change (YoY)
0.00%0.03%0.09%3.95%2.15%-
Upgrade
EPS (Basic)
41.9846.9047.4473.8163.0749.88
Upgrade
EPS (Diluted)
41.9846.8947.4373.6462.9949.88
Upgrade
EPS Growth
-1.05%-1.14%-35.59%16.91%26.29%71.05%
Upgrade
Free Cash Flow
8,3226,0691,4302,7943,7625,063
Upgrade
Free Cash Flow Per Share
50.5236.848.6916.9823.7732.67
Upgrade
Dividend Per Share
-20.000----
Upgrade
Gross Margin
54.11%54.92%48.70%48.89%53.52%53.84%
Upgrade
Operating Margin
15.16%17.45%24.40%31.81%34.75%32.69%
Upgrade
Profit Margin
11.74%13.64%21.55%27.53%28.79%29.35%
Upgrade
Free Cash Flow Margin
14.13%10.71%3.95%6.35%10.86%19.23%
Upgrade
EBITDA
12,57313,13810,31015,10213,0209,553
Upgrade
EBITDA Margin
21.35%23.19%28.44%34.32%37.60%36.28%
Upgrade
D&A For EBITDA
3,6453,2531,4661,101985.75943.97
Upgrade
EBIT
8,9289,8858,84414,00012,0348,609
Upgrade
EBIT Margin
15.16%17.45%24.40%31.81%34.75%32.69%
Upgrade
Effective Tax Rate
34.54%31.79%25.94%25.14%25.31%22.16%
Upgrade
Revenue as Reported
60,80858,35038,65146,24635,97727,724
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.